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LETTERS TO THE EDITORFLOWATCH DEVICE FOR
ADJUSTABLE PULMONARY
ARTERY BANDING
To the Editor:
In a recent article, Di Bardino and
colleagues1 once again are stressing
the importance of having an adjust-
able device for pulmonary artery
banding available in the surgical ar-
mamentarium, particularly for the
management of complex patients,
such as those who require left ventric-
ular retraining.2,3
The advantages of an adjustable de-
vice for pulmonary artery banding
have been proved in other categories of
congenital heart defects, such as func-
tionally univentricular hearts,3 multiple
ventricular septal defects,3 and com-
plete atrioventricular septal defects.4
In all the above categories, includ-
ing congenital heart defects requiring
left ventricular retraining, the favor-
able results obtained by the implanta-
tion of the adjustable FloWatch device
(Leman Medical Technologies SA,
Lausanne, Switzerland) have been re-
ported.2-4
Di Bardino and colleagues,1 recog-
nizing that ‘‘the FloWatch device is
conceptually sound,’’ report that the
device ‘‘is not available in the United
States and is not applicable to all size
patients and all anatomic subtypes.’’
Although it is true that the device
has not received Food and Drug Ad-
ministration approval, it is possible
to obtain limited authorization for im-
plantation in patients in the United
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already done for endless other medical
devices with the CE mark (European
equivalent to Food and Drug Adminis-
tration approval).
With regard to the statement that
the FloWatch device ‘‘is not applica-
ble to all size patients and all anatomic
subtypes,’’ a clarification is required.
The implantation of a FloWatch de-
vice is generally possible even in neo-
nates with a body weight of 2.5 kg or
greater, for all types of congenital
heart defects.2-5
In patients with an anterior aorta,
such as those who require left ventricu-
lar retraining,1,2 there is the risk of
potential coronary artery compression
by the box of the device, by necessity
positioned posteriorly to the ascending
aorta to avoid device compression
at the moment of sternal closure.
Nevertheless, personal and reported
experience proved the feasibility of
this technique even in small neonates.2,3
The same is true for patients with
late referral for left ventricular retrain-
ing, when presentingwith a large sized
pulmonary artery. The FloWatch de-
vice has been successfully implanted
in a patient aged 3 years with a main
pulmonary artery diameter of 3.2 cm.
Finally, for patients with late refer-
ral, potentially requiring a longer
period with the device in situ, the pul-
monary artery can grow and remain
pliable up to 14 months after the de-
vice implantation.5
These clarifications should be use-
ful to expand the use of the FloWatch
device, with several clinical advan-
tages already proved by reports from
different hospitals across Europe.
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To the Editor:
We were greatly interested in the
recent article by Pirbodaghi and col-
leagues,1 in which they looked into
the influence of rotary blood pump
speed change in synchronization with
electrocardiogram. We are pleased to
know that the rotational speed change
with waveform modulation and phase
change is an additional method to
control cardiac workload. However,
several reports demonstrating similar
results have been already published,
although the authors did not refer to
them. For example, Ando and col-
leagues2 showed the efficacy of the
pulsatile mode with increased rota-
tional speed in the systolic phase in re-
lation to the change in arterial pulse
pressure, maximum derivative of pres-
sure over time, and energy equivalent
pulse pressure. In addition, Umeki and
colleagues3 demonstrated an ability of
the newly developed rotational speed
control algorithm called the ‘‘native
heart load control system’’ to control
left ventricular end-diastolic volume,
which was increased in the co-pulse
mode and decreased in the counter-
pulse mode. Furthermore, an acute
Letters to the Editorheart failure model, created by micro-
embolization of the coronary artery,
was used in their study, and they clearly
demonstrated that the impaired cardiac
function madeworkload control easier.
Pirbodaghi and colleagues1 evalu-
ated coronary flow in response to
rotational speed change. However, pre-
vious studies4 have already reported
that coronary flow is diminished as
left ventricular assist device support is
increased, and the increased rotational
speed in the diastolic phase optimizes
coronary flow. As Pirbodaghi and col-
leagues mentioned, the coronary ar-
teries have an autoregulatory system
that maintains optimal coronary flow
according to oxygen demand. There-
fore, the coronary flow with the pulsa-
tile control system should be examined
in ischemic heart models when consid-
ering practical clinical settings.
Pirbodaghi and colleagues1 discuss
that unloading of the left ventricle be-
came a method to promote cardiac re-
covery. In their study, they were able
to control cardiac workload by chang-
ing the rotational speed of a rotary
blood pump via synchronization with
the electrocardiogram. We believe
that unloading is not the only method
of cardiac functional recovery. In
fact, excessive unloading of the left
ventricle might lead to cardiac disuse
atrophy.5 Instead, favorable work for
the native heart in each phase of car-
diac recovery is extremely important
to obtain the best improvement of car-
diac function.
In summary, we were greatly inter-
ested in Pirbodaghi and colleagues’1
idea of rotational speed change with
waveform modulation for controlling
native cardiac load and hemodynam-
ics, and look forward to these authors’
further reports. However, we feel
compelled to point out that the control
system of the rotational speed change
in synchronization with the native car-
diac cycle described by Pirbodaghi
and colleagues1 is similar to previous
studies2-4 and the authors are remiss
in failing to mention these other
articles. We also need to point outThe Journalthat the impaired cardiac function
model, which is very important for
investigating the efficacy of this
novel pump control method in actual
clinical settings, may lead to
different results, as shown by Umeki
and colleagues.3
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We appreciate the comments and
concerns expressed by Arakawa and
colleagues regarding our article, titled
‘‘Pulsatile control of rotary blood
pumps: Does the modulation wave-
form matter?’’1
Unfortunately, we have to disagree
with Arakawa and colleagues. As isof Thoracic and Cardiovascular Surgerobvious from the title of our article, it
investigates the effect of differentwave-
forms on the heart–device interaction.
In contrast to the authors’ claim, this is
the first article in the literature that
uses basic waveforms (sine, triangle,
saw tooth, and rectangular) with differ-
ent phase shifts to examines their im-
pact on left ventricular unloading. The
previous publications2-4 just varied
the pump speed during systole and
diastole, which was first reported by
Bearnson and associates5 in 1996, and
studied its effect on aortic pressure, cor-
onary flow, and end-diastolic volume.
We should mention that dp/dtmax is
a load-sensitive parameter of contractil-
ity and not representative for the degree
of unloading. Moreover, none of the
aforementioned reports has studiedme-
chanical unloading and in particular the
stroke work of the left ventricle. Our
method is unique because we do not
just alternate between high and low
speed but have accurate control of the
waveform because of the direct drive
system of Levitronix Technologies
LLC (Waltham, Mass) and a custom-
developed pump controller.
Without referring, Arakawa and
associates state ‘‘several previous stud-
ies have already reported the coronary
flow diminishes as the left ventricular
assist device support increases.’’ It
should be noted that all the waveforms
used inour studyhave2000 rpmaverage
value with 1000 rpm amplitude, which
is not an excessive speed for the Centri-
Mag rotary pump (Levitronix) to col-
lapse the ventricle and diminish the
coronary flow.
We agree with Arakawa and co-
workers that there is a need for a heart
failuremodel to come tomore relevant
resultswith respect to clinical expecta-
tions. However, we have explored
many existing models, including spe-
cies and breeds that have a native
proneness to cardiomyopathy, but all
of them differ from the genetic presen-
tation in humans. We certainly do not
believe that the use of microemboliza-
tion, in which the coronary circulation
is impaired by the injection ofy c Volume 145, Number 4 1145
